An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression

Journal of Neurochemistry

Volumn 74, Issue 2, 2000, Pages 472-477

  Zimprich, Alexander ^b   Kraus, Jürgen ^b   Wöltje, Michael ^b   Mayer, Peter ^a   Rauch, Elisabeth ^b   Höllt, Volker ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gene promoter; Heroin; Polymorphism; Prodynorphin; Tandem repeat

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DIAMORPHINE; DNA; DYNORPHIN; NUCLEAR PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PRODYNORPHIN; TRANSCRIPTION FACTOR AP 1;

ALLELISM; ANIMAL CELL; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROPHORETIC MOBILITY; GENOTYPE; HEROIN DEPENDENCE; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TANDEM REPEAT;

ALLELES; BASE SEQUENCE; BINDING SITES; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DNA; ENKEPHALINS; GENE EXPRESSION; GENE FREQUENCY; HEROIN DEPENDENCE; HUMANS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; REFERENCE VALUES; TANDEM REPEAT SEQUENCES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; VARIATION (GENETICS);

EID: 0033954670     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.740472.x     Document Type: Article

References (40)

1. Akil H., Meng F., Devine D. P., and Watson S. J. (1997) Molecular and neuroanatomical properties of the endogenous opioid system: implications for treatment of opiate addiction. Semin. Neurosci. 9, 70-84.
2. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., and Karin M. (1987) Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulaled trans-acting factor. Cell 6, 729-739.
3. Blum K., Noble E. P., Sheridan P. J., Montgomery A., Ritchie T., Jagadeeswaran P., Nogami H., Briggs A. H., and Cohn J. B. (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 15, 2055-2060.
4. Bolos A. M., Dean M., Lucas-Derse S., Ramsburg M., Brown G. L., and Goldman D. (1990) Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA 24, 3156-3160.
5. Chen C. and Okayama H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 8, 2745-2752.
6. Douglass J., McKinzie A. A., and Pollock K. M. (1994) Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol. Endocrinol. 8, 333-344.
7. Funada M., Suzuki T., Narita M., and Nagase H. (1993) Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32, 1315-1323.
8. Geijer T., Jonsson E., Neiman J., Gyllander A., Sedvall G., Rydberg U., and Terenius L. (1997) Prodynorphin allelic distribution in Scandinavian chronic alcoholics. Alcohol Clin. Exp. Res. 1, 1333-1336.
9. Gelernter J., O'Malley S., Risch N., Kranzler H. R., Krystal J., Merikangas K., Kennedy J. L., and Kidd K. K. (1991) No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 13, 1801-1807.
10. Grove W. M., Eckert E. D., Heston L., Bouchard T. J. Jr., Segal N., and Lykken D. T. (1990) Heritability of substance abuse and antisocial behavior: a study of monozygotic twins reared apart. Biol. Psychiatry 12, 1293-1304.
11. Herz A. (1998) Opioid reward mechanisms: a key role in drug abuse? Can. J. Physiol. Pharmacol. 76, 252-258.
12. Höllt V. (1993) Regulation of opioid gene expression, in Handbook of Experimental Pharmacology, Vol. 104: Opioids I (Herz A., ed), pp. 307-346. Springer-Verlag, Berlin.
13. Horikawa S., Takai T., Toyosato M., Takahashi H., Noda M., Kakidani H., Kubo T., Hirose T., Inayama S., Hayashida H., Miyata T., and Numa S. (1983) Isolation and structural organization of the human preproenkephalin B gene. Nature 306, 611-614.
14. Hurd Y. L., Herman M. M., Hyde T. M., Biegelow L. B., Weinberger D. R., and Kleinman J. E. (1997) Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects. Mol. Psychiatry 6, 495-500.
15. Imbe H. and Ren K. (1999) Orofacial deep and cutaneous tissue inflammation differentially upregulates preprodynorphin mRNA in the trigeminal and paratrigeminal nuclei of the rat. Brain Res. Mol. Brain Res. 67, 87-97.
16. Khachaturian H., Lewis M. E., Schäfer M. K., and Watson S. J. (1985) Anatomy of the CNS opioid systems. Trends Neurosci. 5, 111-119.
17. Lesch K. P., Bengel D., Heils A., Sabol S. Z., Greenberg B. D., Petri S., Benjamin J., Muller C. R., Hamer D. H., and Murphy D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
18. Luckow B. and Schütz G. (1987) CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 13, 5490.
19. Maniatis T., Fritsch E. F., and Sambrook J. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Press. Cold Spring Harbor, New York.
20. Mathieu-Kia A. M. and Besson M. J. (1998) Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Brain Res. Mol. Brain Res. 54, 141-151.
21. Mayer P., Rochlitz H., Rauch E., Rommelspacher H., Hasse H. E., Schmidt S., and Hollt V. (1997) Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport 11, 2547-2550.
22. Messersmith D. J., Gu J., Dubner R., Douglass J., and Iadarola M. J. (1994) Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter. Mol. Cell. Neurosci. 5, 238-245.
23. Messersmith D. J., Kim D. J., and Iadarola M. J. (1998) Transcription factor regulation of prodynorphin gene expression following rat hindpaw inflammation. Brain Res. Mol. Brain Res. 53, 260-269.
24. Minami M. and Satoh M. (1995) Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res. 23, 121-145.
25. Naranjo J. R., Mellstrom B., Achaval M., and Sassone-Corsi P. (1991) Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 6, 607-617.
26. Ohara K., Nagai M., Tani K., Nakamura Y., Ino A., and Ohara K. (1998) Functional polymorphism of -141C Ins/del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res. 81, 117-123.
27. Okuyama Y., Ishiguro H., Toru M., and Arinami T. (1999) A genetic polymorphism in the promoter region of DRD4 associated with expression of schizophrenia. Biochem. Biophys. Res. Commun. 258, 292-295.
28. Pfeiffer A., Brantl V., Herz A., and Emrich H. M. (1986) Psychotomimesis mediated by κ opiate receptors. Science 233, 774-776.
29. Przewlocka B., Turchan J., Lason W., and Przewlocki R. (1997) Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci. Lett. 238, 13-16.
30. Rosenthal N. E., Mazzanti C. M., Barnett R. L., Hardin T. A., Turner E. H., Lam G. K., Ozaki N., and Goldman D. (1998) Role of serotonin transporter promoter repeat length polymorphism (5-HTTLRP) in seasonally and seasonal affective disorder. Mol. Psychiatry 3, 175-177.
31. Simonato M. and Romualdi P. (1996) Dynorphin and epilepsy. Prog. Neurobiol. 50, 557-583. [Erratum appears in Prog. Neurobiol. (1997) 51, 223-224.]
32. Simpson J. N. and McGinty J. F. (1995) Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry. Synapse 19, 151-159.
33. Smith S. S., O'Hara B. F., Persico A. M., Gorelick D. A., Newlin D. B., Vlahov D., Solomon L., Pickens R., and Uhl G. R. (1992) Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch. Gen. Psychiatry 9, 723-727.
34. Svensson P. and Hurd Y. L. (1998) Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence. Brain Res. Mol. Brain Res. 56, 162-168.
35. Tachibana T., Miki K., Fukuoka T., Taniguchi M., Maruo S., and Noguchi K. (1998) Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization. J. Neurotrauma 15, 485-494.
36. 1] dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice. J. Pharmacol. Exp. Ther. 266, 121-124.
37. Telkov M., Geijer T., and Terenius L. (1998) Human prodynorphin gene generates several tissue-specific transcripts. Brain Res. 804, 284-295.
38. Wang X. M., Zhou Y., Spangler R., Ho A., Han J. S., and Kreek M. J. (1999) Acute intermittent morphine increases preprodynorphin and kappa opioid receptor mRNA levels in the rat brain. Brain Res. Mol. Brain Res. 66, 184-187.
39. Wen H. L. and Ho W. K. (1982) Suppression of withdrawal symptoms by dynorphin in heroin addicts. Eur. J. Pharmacol. 82, 183-186.
40. Wöltje M., Kraus J., and Höllt V. (1998) Identification of a functional 3′5′-cyclic adenosine monophosphate response element within the second promoter of the mouse somatostatin receptor type 2 gene. FEBS Lett. 440, 107-110.